Molecular & Cellular Oncology (Jul 2018)

SETD2 in MLL-rearranged leukemia – a complex case

  • Anna Skucha,
  • Jessica Ebner,
  • Florian Grebien

DOI
https://doi.org/10.1080/23723556.2018.1503492
Journal volume & issue
Vol. 5, no. 4

Abstract

Read online

Oncogenic MLL-fusion proteins often hijack essential molecular mechanisms during leukemogenesis. The histone methyltransferase SETD2 was implicated in the regulation of transcription, DNA damage and other cellular processes. Recent studies identified a critical role for SETD2 in MLL-rearranged leukemia. These results may help to unravel important functions of SETD2 in hematopoiesis.

Keywords